Navigation Links
Need for considering cardiovascular risks before giving HAART for HIV/aids patients

Physicians treating HIV/AIDS patients with highly active antiretroviral treatment (HAART) needs to be careful// of the cardiac risks involved, says researchers from Belgium.

Highly active antiretroviral treatment can dramatically improve the quality of a HIV/AIDS patient’s life expectancy. This is especially helpful for patients with advanced HIV-1 disease. For this patients will have to have a full commitment to the antiviral treatment for life.

However researchers feel in prescribing HAART treatment for these people, physicians should be careful of the recent evidence of increasing cardiovascular and cerebrovascular accidents that are happening with the treatment.

Researchers feel that people infected with HIV have more risk of cardiovascular mortality on taking the HAART treatment than those who haven’t. HAART is associated with risk factors like increased plasma concentrations of triglycerides, total cholesterol, possibly hypertension, insulin resistance etc. HAART treatment can also induce endothelial dysfunction and thereby increase the risk of coronary disease.

Researchers suggest a total assessment of cardiovascular risk factors in patients who are affected with HIV/AIDS before prescribing the highly active antiretroviral treatment. This will make sure that the treatment is given to patients who are most likely to benefit from it.

The research was published in the British Medical Journal.

Reference: British Medical Journal, June 2005
'"/>




Page: 1

Related medicine news :

1. Britain Reconsidering New Visa Rules for Indian Doctors
2. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
3. People who fight wars may be at high risk of cardiovascular disease
4. Low glycemic diet effective for reducing cardiovascular risk
5. Air pollution to affect diabetes patients’ cardiovascular risks
6. Lower risk of cardiovascular disease from tight glucose control
7. Leisure walks with low cardiovascular exercises work best for weight loss
8. Resilin Protein from Flea can be used for cardiovascular disease
9. Unfit teenagers and adults have a higher risk of cardiovascular diseases.
10. Statins reduces cardiovascular risk but no cancer risk.
11. Gene variants hold clues about vulnerability to cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... ... examination of how God handles sin, including how to let go of lingering guilt and ... ten long years has been waiting to release this powerful insight about forgiveness that the ... the Lord for over twenty years, and he has been preaching and teaching the Word ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and More”: ... issue of world hunger, and shares the simple and achievable answer. “The Land of ... member of the Fairview Missionary Church in Angola, Indiana where he works with the ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... telemedicine solutions, has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable ... is an extension to RMT technology that delivers HD, dynamic, streaming ultrasound images ...
(Date:1/19/2017)... ... January 19, 2017 , ... MB Business Capital, ... $11,250,000 senior credit facility to Sunrise, Florida-based Management Health Systems, LLC, dba MedPro ... facilitate a recapitalization of MedPro led by Harren Equity Partners. Brightwood Capital ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... ALTO, Calif. , Jan. 19, 2017   ... research, is excited to announce that the first ... Cancer Biology  (RP:CB) have been published in eLife ... this project represents the first practical evaluation of ... result in reproducible studies. Unlike other assessments of ...
(Date:1/19/2017)... Marks E-QURE , s 3 ... agreements in Israel and Argentina ... billion global market ... devices for the treatment of advanced wound care, announced today it signed a ... Colombia for the Company,s patented Bio-electrical Signal Therapy device ("BST Device"), ...
(Date:1/19/2017)... The drug delivery technology market is projected ... 1,179.20 billion in 2016, at a CAGR of 7.2% ... diseases, increasing demand for biologics, technological advancements, and new ... this market. Whereas, self-administration & home care and rising ... opportunities for players operating in this market. On the ...
Breaking Medicine Technology: